Can I read Fragment-Based Drug Discovery (Drug Discovery, Volume 47) on EtoBox?

Fragment-Based Drug Discovery (Drug Discovery, Volume 47) by Steven Howard, Chris Abell, David Thurston, Harren Jhoti, Martin Drysdale, Isabelle Krimm, Michael Hann, Iwan de Esch is a nonfiction available to read on EtoBox.

What is Fragment-Based Drug Discovery (Drug Discovery, Volume 47) about?

Fragment-based Drug Discovery Is A Rapidly Evolving Area Of Research, Which Has Recently Seen New Applications In Areas Such As Epigenetics, Gpcrs And The Identification Of Novel Allosteric Binding Pockets. The First Fragment-derived Drug Was Recently Approved For The Treatment Of Melanoma. It Is Hoped That This Approval Is Just The Beginning Of The Many Drugs Yet To Be Discovered Using This Fascinating Technique. This Book Is Written From A Chemist's Perspective And Comprehensively Assesses The Impact Of Fragment-based Drug Discovery On A Wide Variety Of Areas Of Medicinal Chemistry. It Will Prove To Be An Invaluable Resource For Medicinal Chemists Working In Academia And Industry, As Well As Anyone Interested In Novel Drug Discovery Techniques. [editors] Steven Howard, Chris Abell. Includes Index. Mode Of Access: World Wide Web.

Who reads Fragment-Based Drug Discovery (Drug Discovery, Volume 47)?

Author

Steven Howard, Chris Abell, David Thurston, Harren Jhoti, Martin Drysdale, Isabelle Krimm, Michael Hann, Iwan de Esch

Publisher

The Royal Society of Chemistry

Published

2015

Language

EN

ISBN

9781782620938

Category

nonfiction

Subjects

Medical, Science, Chemistry